ANBT
ONC

American National Bank & Trust’s BeOne Medicines Ltd ONC Stock Holding History

American National Bank & Trust’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.99K Hold
14
– – ﹤0.01% 560
2026
Q1 		$4.16K Hold
14
– – ﹤0.01% 553
2025
Q4 		$4.25K Buy
+14
New +$4.58K ﹤0.01% 582

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

American National Bank & Trust's ONC Position: Q2 2026 in Review

American National Bank & Trust held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 14 shares worth $3.99K. The position accounts for ﹤0.01% of the portfolio, ranked #560.

American National Bank & Trust first reported a position in ONC in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.25K in Q4 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • American National Bank & Trust held 14 shares of BeOne Medicines Ltd worth $3.99K as of Q2 2026.
  • American National Bank & Trust left its BeOne Medicines Ltd share count unchanged in Q2 2026.
  • BeOne Medicines Ltd made up ﹤0.01% of American National Bank & Trust's portfolio in Q2 2026, its #560 holding.
  • American National Bank & Trust first reported a position in BeOne Medicines Ltd in Q4 2025 and has held it in 3 quarters since.
  • American National Bank & Trust's BeOne Medicines Ltd position peaked at $4.25K in Q4 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on American National Bank & Trust's 13F filing for Q2 2026, filed 22 Jul 2026.